Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 6/20 | 0.46 |
| ▸ | NPC1 | O15118 | 5/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | MARK4 | Q96L34 | 4/20 | 0.46 |
| ▸ | RAD51 | Q06609 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | MBD2 | Q9UBB5 | 1/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22615008 | 0.85 | RAB9A (0.47) | RAB9ANPC1KMT2AMEN1ALDH1A1 | |
| SCHEMBL24517687 | 0.83 | NPC1 (0.54) | RAB9ANPC1ALDH1A1SMN1; SMN2MARK4 | |
| SCHEMBL24517305 | 0.82 | KDM4E (0.53) | RAB9ANPC1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL24517309 | 0.82 | ALDH1A1 (0.53) | RAB9ANPC1ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL24517390 | 0.80 | RAD51 (0.43) | RAB9ANPC1ALDH1A1SMN1; SMN2RAD51 | |
| SCHEMBL24517330 | 0.80 | PLAU (0.46) | RAB9ANPC1ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL24517111 | 0.80 | NPC1 (0.61) | RAB9ANPC1KMT2AMEN1ALDH1A1 | |
| SCHEMBL24517108 | 0.80 | KDM4E (0.44) | RAB9ANPC1ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL24517691 | 0.79 | NTRK1 (0.46) | RAB9ANPC1ALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL24516940 | 0.78 | ADORA1 (0.43) | RAB9ANPC1ALDH1A1SMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220185822-A1 | SELECTIVE LIGANDS OF HUMAN CONSTITUTIVE ANDROSTANE RECEPTOR | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) | 2022-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220185822-A1 | SELECTIVE LIGANDS OF HUMAN CONSTITUTIVE ANDROSTANE RECEPTOR | NR1I2, NR1H2, NR1H4 | RAB9A 4268/4885NPC1 366/4885KMT2A 4487/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.